IDXX News and Press, IDEXX Laboratories Inc.

IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, has scheduled the release of its 2024 second quarter results for Tuesday, August 6, 2024, before the market opens. The Company will conduct an analyst conference call beginning at 8:30 a.m. EDT on that day. ...

2024-06-24 08:00:11 ET Jonathan Block from Stifel Nicolaus issued a price target of $510.00 for IDXX on 2024-06-24 07:19:00. The adjusted price target was set to $510.00. At the time of the announcement, IDXX was trading at $495.73. The overall price target consensus is ...

2024-06-20 21:56:16 ET Summary Baron Capital's 13F stock portfolio value decreased slightly this quarter to $37.52B. Top five stakes include Tesla Motors, Gartner Inc, Arch Capital Group, CoStar Group, and MSCI Inc, totaling ~27% of the portfolio. Stake increases in Red Rock R...

IDEXX Expands Test Menu for the Catalyst Platform to Support Veterinarians Globally in Diagnosing Pancreatitis Canada NewsWire The launch of the Catalyst ® Pancreatic Lipase Test demonstrates IDEXX's Technology for Life strategy and will provide veterinarians with qua...

2024-05-29 06:00:00 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Nothing is guaranteed in the market, but I have good personal conviction in several “Surefire” stocks to buy regularly. This is mostly due to how sticky their revenue and profits ...

2024-05-28 08:24:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

2024-05-27 23:22:25 ET Summary Fundsmith's 13F portfolio value increased from $23.89B to $25.55B this quarter. The top three holdings in the portfolio are Microsoft, Meta Platforms, and Stryker Corp. New stakes were established in Texas Instruments and Choice Hotels, while sta...

2024-05-26 12:20:00 ET Summary Conestoga Capital Advisors LLC is a boutique, independent investment advisory firm specializing in the management of Micro, Small, SMid and Mid Cap Growth equities. Conestoga Capital Advisors utilizes a fundamental, bottom-up research process and employs...

2024-05-22 11:07:09 ET More on CureVac BV, GSK, etc. GSK plc (GSK) Q1 2024 Earnings Call Transcript CureVac N.V. (CVAC) Q4 2023 Earnings Call Transcript CureVac N.V. 2023 Q4 - Results - Earnings Call Presentation GSK succeeds in late-stage trials for asthma c...

2024-05-18 09:16:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...